Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 18 de 18
Filter
1.
Eur Cell Mater ; 41: 345-354, 2021 03 17.
Article in English | MEDLINE | ID: mdl-33729540

ABSTRACT

Clinical management of delayed healing or non-union of long bone fractures and segmental defects poses a substantial orthopaedic challenge. There are suggestions in the literature that bone healing may be enhanced by inhibiting the activities of T and B lymphocytes, but this remains controversial. To examine this matter in more detail, sub-critical-sized segmental defects were created in the femora of mice and it was assessed whether there might be a benefit from the administration of a Food and Drug Administration (FDA)-approved drug that blocks T cell activation (tacrolimus). Defects were stabilised using an internal plate. In certain groups of animals, 1 mg/kg or 10 mg/kg tacrolimus was delivered locally to the defect site for 3 or 7 d using an implanted osmotic pump with a silicon catheter directing drug delivery into the defect area. Healing was monitored by weekly X-ray and assessed at 12 weeks by mechanical testing, µCT and histology. Radiographic and histological evaluations revealed that 100 % of defects healed well regardless of tacrolimus dosage or duration. A comparison of healed C57BL/6 and Rag1-/- femora by µCT and ex vivo torsion testing showed no differences within mouse strains in terms of bone volume, tissue volume, bone volume/tissue volume ratio, shear modulus, torsional rigidity or torsional stiffness. These data failed to support an important role for tacrolimus in modulating the natural healing of segmental defects under those experimental conditions.


Subject(s)
Fracture Healing/drug effects , Fractures, Bone/drug therapy , Fractures, Bone/metabolism , Homeodomain Proteins/metabolism , Tacrolimus/pharmacology , Animals , B-Lymphocytes/drug effects , B-Lymphocytes/metabolism , Femur , Male , Mice , Mice, Inbred C57BL , Osteotomy/methods , T-Lymphocytes/drug effects , T-Lymphocytes/metabolism , X-Ray Microtomography/methods
2.
Clin Exp Allergy ; 48(10): 1297-1304, 2018 10.
Article in English | MEDLINE | ID: mdl-29808611

ABSTRACT

BACKGROUND: Identifying metabolomic profiles of children with asthma has the potential to increase understanding of asthma pathophysiology. OBJECTIVE: To identify differences in plasma metabolites between children with and without current asthma at mid-childhood. METHODS: We used untargeted mass spectrometry to measure plasma metabolites in 237 children (46 current asthma cases and 191 controls) in Project Viva, a birth cohort from eastern Massachusetts, USA. Current asthma was assessed at mid-childhood (mean age 8.0 years). The ability of a broad spectrum metabolic profile to distinguish between cases and controls was assessed using partial least squares discriminant analysis. We used logistic regression models to identify individual metabolites that were differentially abundant by case-control status. We tested significant metabolites for replication in 411 children from the VDAART clinical trial. RESULTS: There was no evidence of a systematic difference in the metabolome of children reporting current asthma vs. healthy controls according to partial least squares discriminant analysis. However, several metabolites were associated with odds of current asthma at a nominally significant threshold (P < .05), including a metabolite of nicotinamide (N1-Methyl-2-pyridone-5-carboxamide (Odds Ratio (OR) = 2.8 (95% CI 1.1-8.0)), a pyrimidine metabolite (5,6-dihydrothymine (OR = 0.4 (95% CI 0.2-0.9)), bile constituents (biliverdin (OR = 0.4 (95%CI 0.1-0.9), taurocholate (OR = 2.0 (95% CI 1.2-3.4)), two peptides likely derived from fibrinopeptide A (ORs from 1.6 to 1.7), and a gut microbiome metabolite (p-cresol sulphate OR = 0.5 (95% CI 0.2-0.9)). The associations for N1-Methyl-2-pyridone-5-carboxamide and p-cresol sulphate replicated in the independent VDAART population (one-sided P values = .03-.04). CONCLUSIONS AND CLINICAL RELEVANCE: Current asthma is nominally associated with altered levels of several metabolites, including metabolites in the nicotinamide pathway, and a bacterial metabolite derived from the gut microbiome.


Subject(s)
Asthma/blood , Biomarkers/blood , Metabolome , Metabolomics , Asthma/diagnosis , Asthma/immunology , Case-Control Studies , Child , Chromatography, Liquid , Female , Humans , Male , Mass Spectrometry , Metabolomics/methods , Odds Ratio
3.
J Neurophysiol ; 116(4): 1564-1578, 2016 10 01.
Article in English | MEDLINE | ID: mdl-27385800

ABSTRACT

Patch clamp is the main technique for measuring electrical properties of individual cells. Since its discovery in 1976 by Neher and Sakmann, patch clamp has been instrumental in broadening our understanding of the fundamental properties of ion channels and synapses in neurons. The conventional patch-clamp method requires manual, precise positioning of a glass micropipette against the cell membrane of a visually identified target neuron. Subsequently, a tight "gigaseal" connection between the pipette and the cell membrane is established, and suction is applied to establish the whole cell patch configuration to perform electrophysiological recordings. This procedure is repeated manually for each individual cell, making it labor intensive and time consuming. In this article we describe the development of a new automatic patch-clamp system for brain slices, which integrates all steps of the patch-clamp process: image acquisition through a microscope, computer vision-based identification of a patch pipette and fluorescently labeled neurons, micromanipulator control, and automated patching. We validated our system in brain slices from wild-type and transgenic mice expressing channelrhodopsin 2 under the Thy1 promoter (line 18) or injected with a herpes simplex virus-expressing archaerhodopsin, ArchT. Our computer vision-based algorithm makes the fluorescent cell detection and targeting user independent. Compared with manual patching, our system is superior in both success rate and average trial duration. It provides more reliable trial-to-trial control of the patching process and improves reproducibility of experiments.


Subject(s)
Algorithms , Automation, Laboratory , Image Processing, Computer-Assisted , Microscopy, Fluorescence , Patch-Clamp Techniques/methods , Animals , Automation, Laboratory/instrumentation , Calibration , Computer Graphics , Female , Fluorescent Dyes , Immunohistochemistry , Male , Mice, Inbred C57BL , Mice, Transgenic , Microscopy, Fluorescence/instrumentation , Microscopy, Fluorescence/methods , Neurons/cytology , Neurons/physiology , Patch-Clamp Techniques/instrumentation , Time Factors , Tissue Culture Techniques , User-Computer Interface , Visual Cortex/cytology , Visual Cortex/physiology
4.
Oncogene ; 35(4): 468-78, 2016 Jan 28.
Article in English | MEDLINE | ID: mdl-25893298

ABSTRACT

Hematogenous metastases are rarely present at diagnosis of ovarian clear cell carcinoma (OCC). Instead dissemination of these tumors is characteristically via direct extension of the primary tumor into nearby organs and the spread of exfoliated tumor cells throughout the peritoneum, initially via the peritoneal fluid, and later via ascites that accumulates as a result of disruption of the lymphatic system. The molecular mechanisms orchestrating these processes are uncertain. In particular, the signaling pathways used by malignant cells to survive the stresses of anchorage-free growth in peritoneal fluid and ascites, and to colonize remote sites, are poorly defined. We demonstrate that the transmembrane glycoprotein CUB-domain-containing protein 1 (CDCP1) has important and inhibitable roles in these processes. In vitro assays indicate that CDCP1 mediates formation and survival of OCC spheroids, as well as cell migration and chemoresistance. Disruption of CDCP1 via silencing and antibody-mediated inhibition markedly reduce the ability of TOV21G OCC cells to form intraperitoneal tumors and induce accumulation of ascites in mice. Mechanistically our data suggest that CDCP1 effects are mediated via a novel mechanism of protein kinase B (Akt) activation. Immunohistochemical analysis also suggested that CDCP1 is functionally important in OCC, with its expression elevated in 90% of 198 OCC tumors and increased CDCP1 expression correlating with poor patient disease-free and overall survival. This analysis also showed that CDCP1 is largely restricted to the surface of malignant cells where it is accessible to therapeutic antibodies. Importantly, antibody-mediated blockade of CDCP1 in vivo significantly increased the anti-tumor efficacy of carboplatin, the chemotherapy most commonly used to treat OCC. In summary, our data indicate that CDCP1 is important in the progression of OCC and that targeting pathways mediated by this protein may be useful for the management of OCC, potentially in combination with chemotherapies and agents targeting the Akt pathway.


Subject(s)
Adenocarcinoma, Clear Cell/mortality , Adenocarcinoma, Clear Cell/pathology , Antigens, CD/metabolism , Cell Adhesion Molecules/metabolism , Neoplasm Proteins/metabolism , Ovarian Neoplasms/mortality , Ovarian Neoplasms/pathology , Adenocarcinoma, Clear Cell/metabolism , Animals , Antigens, CD/analysis , Antigens, CD/genetics , Antigens, Neoplasm , Carboplatin/pharmacology , Cell Adhesion Molecules/analysis , Cell Adhesion Molecules/genetics , Cell Line, Tumor/drug effects , Cell Movement , Drug Resistance, Neoplasm/drug effects , Female , Humans , Kaplan-Meier Estimate , Mice, Inbred NOD , Neoplasm Proteins/analysis , Neoplasm Proteins/genetics , Ovarian Neoplasms/metabolism , Proto-Oncogene Proteins c-akt/metabolism , Spheroids, Cellular/metabolism , Spheroids, Cellular/pathology , Xenograft Model Antitumor Assays
5.
Pharmacogenomics J ; 15(3): 272-7, 2015 Jun.
Article in English | MEDLINE | ID: mdl-25266681

ABSTRACT

Several reports have shown that statin treatment benefits patients with asthma; however, inconsistent effects have been observed. The mir-152 family (148a, 148b and 152) has been implicated in asthma. These microRNAs suppress HLA-G expression, and rs1063320, a common SNP in the HLA-G 3'UTR that is associated with asthma risk, modulates miRNA binding. We report that statins upregulate mir-148b and 152, and affect HLA-G expression in an rs1063320-dependent fashion. In addition, we found that individuals who carried the G minor allele of rs1063320 had reduced asthma-related exacerbations (emergency department visits, hospitalizations or oral steroid use) compared with non-carriers (P=0.03) in statin users ascertained in the Personalized Medicine Research Project at the Marshfield Clinic (n=421). These findings support the hypothesis that rs1063320 modifies the effect of statin benefit in asthma, and thus may contribute to variation in statin efficacy for the management of this disease.


Subject(s)
Asthma/drug therapy , Asthma/genetics , HLA-G Antigens/genetics , Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use , Polymorphism, Single Nucleotide/genetics , 3' Untranslated Regions/genetics , Alleles , Cell Line, Tumor , Female , Hep G2 Cells , Humans , Male , MicroRNAs/genetics , Middle Aged , Risk
6.
Calcif Tissue Int ; 92(6): 566-75, 2013 Jun.
Article in English | MEDLINE | ID: mdl-23460341

ABSTRACT

Monocyte chemotactic protein-1 (MCP-1) belongs to the CC chemokine superfamily and plays a critical role in the recruitment and activation of leukocytes during acute inflammation. We hypothesize that MCP-1 is also an important chemokine that regulates the recruitment and activation of bone cells required for skeletal repair and remodeling. We used the ulnar stress fracture (SFx) model, which allows investigation of focal remodeling with a known time course and precise anatomical location. SFx were created in the right ulna of female Wistar rats using cyclic end loading. Unloaded animals were used as a control. Rats were killed 4 h and 1, 4, 7, and 14 days after loading (n = 10/group); RNA was extracted and converted to cDNA for quantitative PCR analysis using TaqMan gene expression assays. Four hours after loading, MCP-1 gene expression was increased ~30-fold (P < 0.001), remained elevated at 24 h (~12-fold, P < 0.001), then declined by day 14. Relative to the contralateral limb, expression of the receptors CCR1 and CCR2 increased over the 14 days, being significant by 4 days for CCR1 and 14 days for CCR2 (P < 0.05). Other inflammation-related chemokines (RANTES, MIP1a) were not increased at these early time points. Using in situ hybridization and immunohistochemistry in separate animal groups (n = 5/group, control, days 1, 4, 7), MCP-1 mRNA and protein were localized in periosteal osteoblasts associated with woven bone formation at the fracture exit point but not in osteocytes adjacent to the SFx. These data support an important role for MCP-1 in the early phase of SFx repair and activated remodeling.


Subject(s)
Bone Remodeling/physiology , Chemokine CCL2/biosynthesis , Fracture Healing/physiology , Fractures, Stress/metabolism , Animals , Disease Models, Animal , Enzyme-Linked Immunosorbent Assay , Female , Immunohistochemistry , In Situ Hybridization , Rats , Rats, Wistar , Real-Time Polymerase Chain Reaction , Reverse Transcriptase Polymerase Chain Reaction , Transcriptome
7.
Pharmacogenomics J ; 13(4): 306-11, 2013 Aug.
Article in English | MEDLINE | ID: mdl-22641026

ABSTRACT

Inhaled corticosteroids (ICS) are the most commonly used controller medications prescribed for asthma. Two single-nucleotide polymorphisms (SNPs), rs1876828 in corticotrophin releasing hormone receptor 1 and rs37973 in GLCCI1, have previously been associated with corticosteroid efficacy. We studied data from four existing clinical trials of asthmatics, who received ICS and had lung function measured by forced expiratory volume in 1 s (FEV1) before and after the period of such treatment. We combined the two SNPs rs37973 and rs1876828 into a predictive test of FEV1 change using a Bayesian model, which identified patients with good or poor steroid response (highest or lowest quartile, respectively) with predictive performance of 65.7% (P=0.039 vs random) area under the receiver-operator characteristic curve in the training population and 65.9% (P=0.025 vs random) in the test population. These findings show that two genetic variants can be combined into a predictive test that achieves similar accuracy and superior replicability compared with single SNP predictors.


Subject(s)
Adrenal Cortex Hormones/administration & dosage , Asthma/drug therapy , Asthma/genetics , Receptors, Glucocorticoid/genetics , Adult , Asthma/pathology , Female , Forced Expiratory Volume/drug effects , Genetic Association Studies , Humans , Male , Middle Aged , Polymorphism, Single Nucleotide , Respiratory Therapy
8.
J Orthop Res ; 29(12): 1827-33, 2011 Dec.
Article in English | MEDLINE | ID: mdl-21598308

ABSTRACT

Because bisphosphonates (BPs) are potent inhibitors of bone resorption, we hypothesized that they would retard direct remodeling of stress fractures. The aim of this study was to determine the effect of risedronate on direct remodeling and woven bone callus formation following stress fracture formation in the rat ulna. In 135 adult female Wistar rats, cyclic loading of the ulna created stress fractures. Rats were treated daily with oral saline, or risedronate at 0.1 or 1.0 mg/kg. From each bone, histomorphometry was performed on sections stained with toluidine blue at a standard level along the fracture. The high dose of risedronate caused a significant decrease in the percentage of repaired stress fracture and bone resorption along the stress fracture line at 6 and 10 weeks after loading (p < 0.05). At this dose, intracortical resorption was significantly reduced at 10 weeks after loading and intracortical new bone area was significantly reduced at 6 and 10 weeks. Woven bone formation and consolidation phases of stress fracture repair were not affected by low or high doses of risedronate. In conclusion, high dose bisphosphonate treatment impaired healing of a large stress fracture line by reducing the volume of bone resorbed and replaced during remodeling. We also confirmed that periosteal callus formation was not adversely affected by risedronate treatment.


Subject(s)
Bone Density Conservation Agents/pharmacology , Bone Remodeling/drug effects , Etidronic Acid/analogs & derivatives , Fractures, Stress/drug therapy , Ulna Fractures/drug therapy , Animals , Bony Callus/drug effects , Diaphyses/drug effects , Diaphyses/injuries , Diphosphonates/pharmacology , Dose-Response Relationship, Drug , Etidronic Acid/pharmacology , Female , Periosteum/drug effects , Rats , Rats, Wistar , Risedronic Acid
9.
Bone ; 46(2): 369-78, 2010 Feb.
Article in English | MEDLINE | ID: mdl-19836476

ABSTRACT

Loading of the rat ulna is an ideal model to examine stress fracture healing. The aim of this study was to undertake a detailed examination of the histology, histomorphometry and gene expression of the healing and remodelling process initiated by fatigue loading of the rat ulna. Ulnae were harvested 1, 2, 4, 6, 8, and 10 weeks following creation of a stress fracture. Stress fracture healing involved direct remodelling that progressed along the fracture line as well as woven bone proliferation at the site of the fracture. Histomorphometry demonstrated rapid progression of basic multicellular units from 1 to 4 weeks with significant slowing down of healing by 10 weeks after loading. Quantitative PCR was performed at 4 hours, 24 hours, 4 days, 7 days, and 14 days after loading. Gene expression was compared to an unloaded control group. At 4 hours after fracture, there was a marked 220-fold increase (P<0.0001) in expression of IL-6. There were also prominent peak increases in mRNA expression for OPG, COX-2, and VEGF (all P<0.0001). At 24 hours, there was a peak increase in mRNA expression for IL-11 (73-fold increase, P<0.0001). At 4 days, there was a significant increase in mRNA expression for Bcl-2, COX-1, IGF-1, OPN, and SDF-1. At 7 days, there was significantly increased mRNA expression of RANKL and OPN. Prominent, upregulation of COX-2, VEGF, OPG, SDF-1, BMP-2, and SOST prior to peak expression of RANKL indicates the importance of these factors in mediating directed remodelling of the fracture line. Dramatic, early upregulation of IL-6 and IL-11 demonstrate their central role in initiating signalling events for remodelling and stress fracture healing.


Subject(s)
Fracture Healing/genetics , Fractures, Stress/genetics , Fractures, Stress/pathology , Gene Expression Regulation , Ulna Fractures/genetics , Ulna Fractures/pathology , Acid Phosphatase/metabolism , Animals , Female , Isoenzymes/metabolism , RNA, Messenger/genetics , RNA, Messenger/metabolism , Rats , Rats, Wistar , Tartrate-Resistant Acid Phosphatase , Time Factors , Ulna Fractures/enzymology
10.
Clin Pharmacol Ther ; 84(2): 272-4, 2008 Aug.
Article in English | MEDLINE | ID: mdl-18580869

ABSTRACT

Ever since the sequencing of the human genome was completed, prediction of treatment response in terms of genetic variation has been seen as an important and achievable goal. Pharmacogenetics is the study of how genetic differences affect variation in response to medication. One potential goal of pharmacogenetics is to be able to deliver "personalized medicine" by making management decisions that optimize patient health outcomes based on a patient's genetic makeup. Pharmacogenetic tests have the potential to (i) predict intended response, the goal outcome of the medication; (ii) predict unintended response to the medication, such as adverse events; (iii) titrate medication dose; and (iv) inform the development of novel therapeutics.


Subject(s)
Genetic Testing/economics , Genetic Variation , Pharmacogenetics/economics , Antibodies, Monoclonal/administration & dosage , Antibodies, Monoclonal/adverse effects , Antibodies, Monoclonal/pharmacokinetics , Antibodies, Monoclonal, Humanized , Anticoagulants/administration & dosage , Anticoagulants/adverse effects , Anticoagulants/pharmacokinetics , Antineoplastic Agents/administration & dosage , Antineoplastic Agents/adverse effects , Antineoplastic Agents/pharmacokinetics , Aryl Hydrocarbon Hydroxylases/genetics , Cytochrome P-450 CYP2C9 , Genetic Techniques/economics , Humans , Mixed Function Oxygenases/genetics , Predictive Value of Tests , Receptor, ErbB-2/genetics , Trastuzumab , Vitamin K Epoxide Reductases , Warfarin/administration & dosage , Warfarin/adverse effects , Warfarin/pharmacokinetics
11.
Apoptosis ; 11(11): 1899-908, 2006 Nov.
Article in English | MEDLINE | ID: mdl-16927023

ABSTRACT

Retinal pigment epithelial (RPE) cells are constantly exposed to oxidative injury while clearing byproducts of photoreceptor turnover, a circumstance thought to be responsible for degenerative retinal diseases. The mechanisms of hydrogen peroxide (H(2)O(2))-induced apoptosis in RPE cells are not fully understood. We studied signal transduction mechanisms of H(2)O(2)-induced apoptosis in the human RPE cell line ARPE-19. Activation of two stress kinases (JNK and p38) occurs during H(2)O(2) stimulation, and H(2)O(2)-mediated cell death was significantly reduced by their specific inhibition. Exposure to a lethal dose of H(2)O(2) elicited Bax translocation to the mitochondria and release of apoptosis-inducing factor (AIF) from the mitochondria, both of which were abolished by either JNK- or p38-specific inhibitors. Both H(2)O(2)-induced cell death and JNK/p38 phosphorylation were partially inhibited by C. difficile toxin B, inhibitor of Rho, Rac, and cdc42. Use of pull-down assays revealed that the small GTPase activated by H(2)O(2) is Rac1. This study is the first to demonstrate that H(2)O(2) induces a Rac1/JNK1/p38 signaling cascade, and that JNK and p38 activation is important for H(2)O(2)-induced apoptosis as well as AIF/Bax translocation of RPE cells.


Subject(s)
Apoptosis , Hydrogen Peroxide/pharmacology , Mitogen-Activated Protein Kinase 8/metabolism , Pigment Epithelium of Eye/cytology , p38 Mitogen-Activated Protein Kinases/metabolism , Active Transport, Cell Nucleus , Anthracenes/pharmacology , Apoptosis/drug effects , Apoptosis Regulatory Proteins/metabolism , Bacterial Proteins/pharmacology , Bacterial Toxins/pharmacology , Cell Line, Tumor , Cell Nucleus/metabolism , Enzyme Inhibitors/pharmacology , Humans , Imidazoles/pharmacology , MAP Kinase Signaling System , Mitogen-Activated Protein Kinase 8/antagonists & inhibitors , Protein Transport , Pyridines/pharmacology , p38 Mitogen-Activated Protein Kinases/antagonists & inhibitors , rac1 GTP-Binding Protein/antagonists & inhibitors
13.
Gen Hosp Psychiatry ; 21(4): 303-9, 1999.
Article in English | MEDLINE | ID: mdl-10514954

ABSTRACT

Despite its merits, the Western-style psychiatric community rehabilitation model is not well accepted by caregivers in Taiwan. We examined factors affecting the utilization of community rehabilitation programs in Taiwan. Our stepwise logistic regression revealed that psychoeducation regarding the biological cause of schizophrenia emerged as the major factor for increasing utilization treatment modality. Eighty-nine pairs of schizophrenic patients (who had been recommended for rehabilitation) and their relatives were divided into two groups, the rehabilitation group and the nonrehabilitation group. Both groups were surveyed on help-seeking behavior scales and mental function measurements. The results showed no significant differences in patients' psychopathology, though the rehabilitation group had higher employment rates. As for caregivers, the rehabilitation group scored significantly better on some cognitive appraisals, whereas the nonrehabilitation group was more inclined to institutionalize the patients for life. No significant differences were noticed on rejection attitude, subjective care burden, or expressed emotion measures. Improving caregiver's knowledge about the disease, providing activities that lend emotional, physical, and financial support and thereby reduce the burden and increase the satisfaction of caregivers may be useful. Besides making the Western-style psychiatric community rehabilitation model more effective and accessible for patients and caregivers in Taiwan, cultural adaptation is also needed.


Subject(s)
Family Health , Family/psychology , Patient Acceptance of Health Care/psychology , Schizophrenia/diagnosis , Schizophrenia/therapy , Adolescent , Adult , Aged , Attitude to Health , Chronic Disease , Female , Humans , Male , Middle Aged , Taiwan
15.
Skeletal Radiol ; 16(4): 312-5, 1987.
Article in English | MEDLINE | ID: mdl-3616669

ABSTRACT

Six cases of distal phalangeal brachydactyly of the hands in patients with healed renal osteodystrophy are reported. Severe osseous changes of renal osteodystrophy were seen in all cases. These cases present healed renal osteodystrophy as another consideration in the differential diagnosis of distal phalangeal brachydactyly.


Subject(s)
Bone Resorption/diagnostic imaging , Bone and Bones/diagnostic imaging , Chronic Kidney Disease-Mineral and Bone Disorder/complications , Fingers/diagnostic imaging , Adult , Bone Resorption/etiology , Chronic Kidney Disease-Mineral and Bone Disorder/therapy , Female , Fingers/metabolism , Humans , Hyperparathyroidism, Secondary/complications , Male , Middle Aged , Radiography
16.
Am J Public Health ; 75(4): 405-6, 1985 Apr.
Article in English | MEDLINE | ID: mdl-3976970

ABSTRACT

Salt intake of 978 subjects when compared to 1954 data demonstrated a trend toward the decreased use of table salt. When hypertensives in treatment were excluded, persons reporting low salt use had higher mean systolic and diastolic blood pressures than those reporting high salt use. These findings were the reverse of the relationships found in 1954.


Subject(s)
Blood Pressure , Diet , Sodium Chloride , Adult , Educational Status , Ethnicity , Female , Humans , Male , Sex Factors , Time Factors
17.
Am J Chin Med ; 8(4): 313-30, 1980.
Article in English | MEDLINE | ID: mdl-7246475

ABSTRACT

Over two years the authors led a massive, government-supported survey of 2,000 Taiwanese families, half urban and half rural, to determine what actions the family would take when faced with disease or health problems. The major alternatives of folk healing, Chinese traditional medicine, and Western-oriented approaches were found to be frequently combined, and often supplemented by self diagnosis and self-medication. Thirty Chinese students entered the 2,000 families' homes for lengthy interviews covering a wide range of socio-demographic variables as well as medical behaviors. Cooperation of informants was outstanding, and the plentiful data from this large sample should provide ample ground for future studies and interpretations. The statistics substantially documented some findings suggested by earlier researchers: (a) that 90% of Taiwanese families combine a variety of approaches in warding off and treating illnesses (1); (b) that there is somewhat higher reliance on purely Western methods among young urban nuclear families, and among mainland-born Christians, than in the rural areas (2); and (c) that Taiwanese families avoid bringing mental health problems to medical or psychiatric health facilities (3). The statistics bear out some fairly predictable conclusions, such as: (a) Western medical methods are known and used more widely in the city than in the country (cf. "a" below); (b) there is more ignorance of facilities and medicines of all kinds in the country than in Taipei; and (c) traditional Chinese medicine is somewhat more used in the country than in Taipei. In addition, some fairly startling new developments are worth noting, including that (a) there is less rural/urban difference than expected--97-99% use some Western methods at some times; (b) while almost no one relies solely on folk healing, more city-dwellers use it (as well as massage and acupuncture) than do rural folk; and (c) urban families often go to private doctors, ignorant of their local public health stations.


Subject(s)
Attitude to Health , Health Services/statistics & numerical data , Adult , Female , Health Surveys , Humans , Male , Medicine, Chinese Traditional , Medicine, Traditional , Middle Aged , Rural Health , Taiwan , Urban Health
18.
J Chromatogr ; 128(1): 87-99, 1976 Nov 17.
Article in English | MEDLINE | ID: mdl-993304

ABSTRACT

Optimal conditions for using high-performance liquid chromatography (HPLC) in the size exclusion mode have been determined for measuring the molecular-weight (MW) distribution of chitosan samples. Physical separation according to molecular size was accomplished on the stationary phase of glass supports having controlled pore sizes ranging from 2500 to 40 A. Selection of column combinations was based on the requirements to resolve the higher MW fraction of chitosan and to give a linear calibration curve within the required MW range. The best combination of glass pore sizes and column lengths in two foot sections joined sequentially was: 2500 A (2 ft.), 1500 A (4 ft.), 550 A (6 ft.), 250 A (2 ft), 100 A (2 ft.), and 40 A (2 ft.). A loading study showed that an injection load of 500 mug, i.e. 100 mul at 5 g/l or 50 mul at 10 g/l (w/v), was the optimal load to give reproducible elution volumes, precision in quantitation, and minimum viscosity effects. The best calibration curve using defined dextran standards was obtained from the geometric mean of Mw (weight average MW) and Mn (number average MW) values and peak elution volumes. Precision in determining MW distribution of chitosan as well as dextran standards was better than 5% relative standard deviation, and the differences between these results and the manufacturer's data on the dextran standards were 6 to -17%. The MW distribution of a selected chitosan samples in 2% acetic acid thus determined was Mw = 2,055,000, Mn = 936,000, dispersity = 2.16, and the most abundant species was around 1,103,000. Analysis time for the HPLC separation was less than 20 min per sample. Chitosan is an effective coagulating agent for the treatment of food processing wastes and activated sludge from biological treatment systems. It is manufactured from chitin in shrimp and crab wastes. The rapid methods developed here for determining the MW distribution of chitosan preparations will be used to optimize the manufacturing process and guide the selection of more effective chitosan products.


Subject(s)
Chromatography, High Pressure Liquid , Molecular Weight , Polysaccharides/analysis , Chitin , Dextrans , Glucosamine/analysis , Methods
SELECTION OF CITATIONS
SEARCH DETAIL
...